Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancer

BACKGROUND: Inhibitors of the kinase mTOR, such as rapamycin and everolimus, have been used as cancer therapeutics with limited success since some tumours are resistant. Efforts to establish predictive markers to allow selection of patients with tumours likely to respond have centred on determining...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Satheesha, Sampoorna, Cookson, Victoria J, Coleman, Louise J, Ingram, Nicola, Madhok, Brijesh, Hanby, Andrew M, Suleman, Charlotte AB, Sabine, Vicky S, Macaskill, E Jane, Bartlett, John MS, Dixon, J Michael, McElwaine, Jim N, Hughes, Thomas A
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2011
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3055230/
https://ncbi.nlm.nih.gov/pubmed/21320304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-10-19
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg